Real-World Use of Alpha-Synuclein Seeding Amplification Assay in a Behavioral Neurology Clinic (P10-3.018)

To characterize use and impact on clinical decision-making of the alpha-synuclein seeding amplification assay (SAA) in a tertiary behavioral neurology clinic.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000212047
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-World Use of Alpha-Synuclein Seeding Amplification Assay in a Behavioral Neurology Clinic (P10-3.018)

Lawren VandeVrede, David F. Fischer, Bruce L. Miller, Tara Ellingson
Neurology
Parkinson's Disease Mechanisms and Treatments
article

Real-World Use of Alpha-Synuclein Seeding Amplification Assay in a Behavioral Neurology Clinic (P10-3.018)

Lawren VandeVrede, David F. Fischer, Bruce L. Miller, Tara Ellingson
article en

Abstract

To characterize use and impact on clinical decision-making of the alpha-synuclein seeding amplification assay (SAA) in a tertiary behavioral neurology clinic.

NeurologyVol. 104(7_Supplement_1)
University Memory and Aging Center (US)
Zero hunger
Openalex Percentile: Top 89%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real-World Use of Alpha-Synuclein Seeding Amplification Assay in a Behavioral Neurology Clinic (P10-3.018) — Lawren VandeVrede, David F. Fischer, et al. · Neurology (2025) | TGRS Research Map | TGRS